AstraZeneca's Global Senior Vice President, AstraZeneca China General Manager, and Oncology Business General Manager Lai Minglong issued an internal letter to all AstraZeneca China employees, stating: The company has learned that President Wang Lei is currently under investigation and cooperating. Please rest assured, the company's operation is normal, and I will continue to lead AstraZeneca's various business developments in China.
阿斯利康中国区内部信:公司运营正常,中国总经理将继续领导公司
AstraZeneca China internal memo: The operation of the company is normal, and the general manager of China will continue to lead the company.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.